Insider Transactions in Q4 2022 at Catalent, Inc. (CTLT)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2022
|
Manja Boerman Pres. BioModalities Division |
SELL
Open market or private sale
|
Direct |
780
-4.69%
|
$39,780
$51.7 P/Share
|
|
Oct 31
2022
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
SELL
Open market or private sale
|
Direct |
2,451
-12.11%
|
$159,315
$65.83 P/Share
|
|
Oct 27
2022
|
Peter Zippelius Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+25.73%
|
-
|
|
Oct 27
2022
|
Christa Kreuzburg Director |
SELL
Payment of exercise price or tax liability
|
Direct |
421
-3.12%
|
$27,786
$66.27 P/Share
|
|
Oct 27
2022
|
Christa Kreuzburg Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+23.54%
|
-
|
|
Oct 27
2022
|
Gregory T Lucier |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+14.11%
|
-
|
|
Oct 27
2022
|
Donald E Morel Jr |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+6.63%
|
-
|
|
Oct 27
2022
|
Jack L Stahl |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+10.25%
|
-
|
|
Oct 27
2022
|
Madhavan Balachandran Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+16.87%
|
-
|
|
Oct 27
2022
|
Michael J Barber |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+39.35%
|
-
|
|
Oct 27
2022
|
J Martin Carroll |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+16.82%
|
-
|
|
Oct 27
2022
|
Rolf A Classon |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+10.25%
|
-
|
|
Oct 27
2022
|
Rosemary A Crane Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+19.73%
|
-
|
|
Oct 27
2022
|
Karen Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+19.3%
|
-
|
|
Oct 27
2022
|
John J Greisch Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
4,149
+19.73%
|
-
|
|
Oct 10
2022
|
Thomas W Hawkeswood Pres. Pharma Prod Delivery Div |
SELL
Open market or private sale
|
Direct |
930
-14.78%
|
$71,610
$77.46 P/Share
|